Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (181-190 of 583) with videos related to

Pageof 59
Sort By:
Cancer|August 15, 1980
Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemiaB A Peterson, C D Bloomfield, G J Bosl, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemiasGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.
Lancet (London, England)|December 18, 1976
Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphomaC D Bloomfield, J H Kersey, R D Brunning, et al.
The Journal of Clinical Investigation|December 1, 1973
B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's diseaseK J Gajl-Peczalska, J A Hansen, C D Bloomfield, et al.
Clinical and Experimental Immunology|August 1, 1974
B-cell markers on lymphoblasts in acute lymphoblastic leukaemiaK J Gajl-Peczalska, C D Bloomfield, M E Nesbit, et al.
Cancer Treatment Reports|September 1, 1977
Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphomaC D Bloomfield, J H Kersey, R D Brunning, et al.
The Oncologist|April 19, 2002
Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxideJames L Slack, Samuel Waxman, Guido Tricot, et al.
Blood|May 1, 1986
The proportion of mitoses in different cell lineages changes during short-term culture of normal human bone marrowM Keinänen, S Knuutila, C D Bloomfield, et al.
Cancer|July 1, 1976
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPPC D Bloomfield, R B Weiss, I Fortuny, et al.
Cancer|March 1, 1974
Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomasC D Bloomfield, A Goldman, F Dick, et al.
Pageof 59

Showing results (181-190 of 583) with videos related to

Sort By:
Pageof 59
Cancer|August 15, 1980
Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemiaB A Peterson, C D Bloomfield, G J Bosl, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemiasGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.
Lancet (London, England)|December 18, 1976
Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphomaC D Bloomfield, J H Kersey, R D Brunning, et al.
The Journal of Clinical Investigation|December 1, 1973
B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's diseaseK J Gajl-Peczalska, J A Hansen, C D Bloomfield, et al.
Clinical and Experimental Immunology|August 1, 1974
B-cell markers on lymphoblasts in acute lymphoblastic leukaemiaK J Gajl-Peczalska, C D Bloomfield, M E Nesbit, et al.
Cancer Treatment Reports|September 1, 1977
Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphomaC D Bloomfield, J H Kersey, R D Brunning, et al.
The Oncologist|April 19, 2002
Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxideJames L Slack, Samuel Waxman, Guido Tricot, et al.
Blood|May 1, 1986
The proportion of mitoses in different cell lineages changes during short-term culture of normal human bone marrowM Keinänen, S Knuutila, C D Bloomfield, et al.
Cancer|July 1, 1976
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPPC D Bloomfield, R B Weiss, I Fortuny, et al.
Cancer|March 1, 1974
Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomasC D Bloomfield, A Goldman, F Dick, et al.
Pageof 59